Compare ALGT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGT | ORIC |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2006 | 2020 |
| Metric | ALGT | ORIC |
|---|---|---|
| Price | $82.79 | $11.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $75.10 | $18.78 |
| AVG Volume (30 Days) | 309.5K | ★ 1.2M |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,578,095,000.00 | N/A |
| Revenue This Year | $5.43 | N/A |
| Revenue Next Year | $2.15 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.29 | N/A |
| 52 Week Low | $39.80 | $3.90 |
| 52 Week High | $107.57 | $14.93 |
| Indicator | ALGT | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 69.97 | 40.42 |
| Support Level | $73.70 | $10.45 |
| Resistance Level | $78.27 | $12.14 |
| Average True Range (ATR) | 4.11 | 0.77 |
| MACD | 1.39 | -0.08 |
| Stochastic Oscillator | 96.28 | 26.05 |
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.